Efficacy of combined 5-fluorouracil and cisplatinum in advanced gastric carcinomas. A phase II trial with prognostic factor analysis
- 31 December 1994
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (9) , 1263-1269
- https://doi.org/10.1016/0959-8049(94)90170-8
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Signet ring cell carcinoma of the stomachCancer, 1992
- Combination chemotherapy with cisplatin and 5-fluorouracil 5-day infusion in the therapy of advanced gastric cancer: A Phase II trialAnnals of Oncology, 1991
- Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group.Journal of Clinical Oncology, 1991
- Current status of chemotherapy for gastric cancerEuropean Journal of Cancer and Clinical Oncology, 1989
- Current status of chemotherapy for advanced pancreatic and gastric cancer.Journal of Clinical Oncology, 1985
- A Comparison of Three Chemotherapeutic Regimens in the Treatment of Advanced Pancreatic and Gastric CarcinomaJAMA, 1985
- Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatinCancer, 1985
- Reporting results of cancer treatmentCancer, 1981
- 5-Fluorouracil, Doxorubicin, and Mitomycin (FAM) Combination Chemotherapy for Advanced Gastric CancerAnnals of Internal Medicine, 1980
- A review of chemotherapy in gastric cancerCancer, 1974